Investors are catching on to this rare gem among pharmaceutical stocks, but thanks to promising growth and a low valuation, further upside remains.
Royalty Pharma plc Class A Ordinary Shares (RPRX) News
Latest headlines that mention RPRX, newest first · each headline opens the original publisher
- Last price
- $56.21
- Day change
- -0.97%
- Next earnings
- 2026-11-04
RPRX headlines
last 30 daysRevolution Medicines' stock is up 330% in a year on drug development progress; you may want to spread your bets with Royalty Pharma instead.
Also mentioned with RPRX
30dHeadlines that tag both tickers
RPRX news alerts
Get an alert by email or push when a new headline mentions RPRX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.